Trademarks = 2

Forward Citations = 5

Loading Chart...

6 inventors (with patents filed for the assignee):

Jason Allan Wiles (9 out of 82 patents)

Mark George Saulnier (9 out of 42 patents)

Kevin Tyler Sprott (9 out of 9 patents)

4. Srinivasa Karra (9 out of 9 patents)

5. Jesse Jingyang Chen (9 out of 9 patents)

6. Soumya Ray (9 out of 9 patents)

9 patents: Sort by Forward Citations

1. 12667620 - ASGPR-BINDING COMPOUNDS FOR THE DEGRADATION OF EXTRACELLULAR PROTEINS (2026-06-30),

2. 12622972 - ASGPR-BINDING COMPOUNDS FOR THE DEGRADATION OF EXTRACELLULAR PROTEINS (2026-05-12),

3. 12312340 - Potent ASGPR-binding compounds for the degradation of immunoglobulins and other proteins (2025-05-27),

4. 12290568 - ASGPR-binding compounds for the degradation of extracellular proteins (2025-05-06),

5. 12280116 - ASGPR-binding compounds for the degradation of extracellular proteins (2025-04-21),

6. 12128106 - ASGPR-binding compounds for the degradation of extracellular proteins (2024-10-29),

7. 12091402 - Potent ASGPR-binding compounds for the degradation of immunoglobulins and other proteins (2024-09-17),

8. 12076408 - ASGPR-binding compounds for the degradation of extracellular proteins (2024-09-03),

9. 11819551 - ASGPR-binding compounds for the degradation of extracellular proteins (2023-11-21),

Company Overview

Avilar Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative therapeutics for the treatment of serious diseases. With a mission to advance patient care, Avilar leverages its proprietary platform to identify and optimize biologic therapies. The company's approach emphasizes precision medicine and aims to address unmet medical needs across various therapeutic areas, including oncology and autoimmune disorders. By harnessing cutting-edge science and technology, Avilar is committed to transforming potential discoveries into effective treatments that enhance the quality of life for patients.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

9 Patents

#136 in Waltham, MA

#1,926 in Massachusetts

#32,605 in US

Waltham, MA, United States of America

Avilar Therapeutics, Inc.

Forward Citations = 5

6 inventors:

Jason Allan Wiles (9 out of 82 patents)

Mark George Saulnier (9 out of 42 patents)

Kevin Tyler Sprott (9 out of 9 patents)

4. Srinivasa Karra (9 out of 9 patents)

5. Jesse Jingyang Chen (9 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Avilar Therapeutics, Inc.. Retrieved from https://idiyas.com/company/avilar-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]